These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29549467)

  • 21. Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy.
    Jauss M; Schütz HJ; Tanislav C; Misselwitz B; Rosenow F
    Eur J Neurol; 2010 Apr; 17(4):555-61. PubMed ID: 20218973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.
    Mione G; Ducrocq X; Thilly N; Lacour JC; Vespignani H; Richard S
    Geriatr Gerontol Int; 2016 Jul; 16(7):843-9. PubMed ID: 26245693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mild stroke: safety and outcome in patients receiving thrombolysis.
    Logallo N; Kvistad CE; Naess H; Waje-Andreassen U; Thomassen L
    Acta Neurol Scand Suppl; 2014; (198):37-40. PubMed ID: 24588505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Baseline Hyperglycemia With Outcomes of Patients With and Without Diabetes With Acute Ischemic Stroke Treated With Intravenous Thrombolysis: A Propensity Score-Matched Analysis From the SITS-ISTR Registry.
    Tsivgoulis G; Katsanos AH; Mavridis D; Lambadiari V; Roffe C; Macleod MJ; Sevcik P; Cappellari M; Nevšímalová M; Toni D; Ahmed N
    Diabetes; 2019 Sep; 68(9):1861-1869. PubMed ID: 31217175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.
    Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB;
    Trials; 2010 May; 11():51. PubMed ID: 20459856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperglycemia predicts unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis among a Chinese population: A prospective cohort study.
    Lin SF; Chao AC; Hu HH; Lin RT; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Sun MH; Wei CY; Lin YT; Lee JT; Bai CH;
    J Neurol Sci; 2018 May; 388():195-202. PubMed ID: 29627022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are the results of intravenous thrombolysis trials reproduced in clinical practice? Comparison of observed and expected outcomes with the stroke-thrombolytic predictive instrument (STPI).
    Decourcelle A; Moulin S; Dequatre-Ponchelle N; Bodenant M; Rossi C; Girot M; Hénon H; Wiel E; Bordet R; Goldstein P; Pruvo JP; Cordonnier C; Leys D
    Rev Neurol (Paris); 2017 Jun; 173(6):381-387. PubMed ID: 28454980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
    Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis.
    Rodrigues FB; Neves JB; Caldeira D; Ferro JM; Ferreira JJ; Costa J
    BMJ; 2016 Apr; 353():i1754. PubMed ID: 27091337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved survival with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic limb-threatening ischemia.
    Khan SZ; O'Brien-Irr MS; Rivero M; Blochle R; Cherr GS; Dryjski ML; Dosluoglu HH; Lukan J; Rowe VL; Harris LM
    J Vasc Surg; 2020 Dec; 72(6):2130-2138. PubMed ID: 32276021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis.
    Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J
    Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous Recombinant Tissue-Type Plasminogen Activator: Influence on Outcome in Anterior Circulation Ischemic Stroke Treated by Mechanical Thrombectomy.
    Ferrigno M; Bricout N; Leys D; Estrade L; Cordonnier C; Personnic T; Kyheng M; Henon H
    Stroke; 2018 Jun; 49(6):1377-1385. PubMed ID: 29748424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Older age is not related to hemorrhagic transformation and favorable outcomes in patients with wake-up ischemic stroke undergoing intravenous thrombolytic therapy].
    Zhai LP; Chen ZC; Yan SQ; Zhong GL; Zhang S; Xu MJ; Lou M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 44(6):638-44. PubMed ID: 26822046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of differences in case mix on the better outcome of smokers after intravenous thrombolysis for acute cerebral ischemia.
    Moulin S; Padjen-Bogosavljevic V; Marichal A; Cordonnier C; Jovanovic DR; Gautier S; Hénon H; Beslac-Bumbasirevic L; Bordet R; Leys D
    Eur Neurol; 2012; 67(3):178-83. PubMed ID: 22286144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
    Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
    Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
    Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.